28730 results
We are prioritizing the review of new ANDAs for drugs in shortage, and we recently approved a generic application for hydroxychloroquine to increase availability for patients who depend on this drug. https://t.co/eKqXlpRRQl

Links:

Dr. Janet Woodcock @DrWoodcockFDA  (  View Tweet)

Please believe that the Coronavirus is not a hoax, COVID-19 is not a conspiracy. Your doubts, ideology and slick videos cant change nearly 100,000 Americans dying from COVID in 3 short months. Please be vigilant with Distance, washing and masks

Dr. John Cush @RheumNow  (  View Tweet)

Grand News and much Deserved. Congrats Professor Shanmugam!! https://t.co/jUjEv9dQuM

Links:

Dr. John Cush @RheumNow  (  View Tweet)

Effect of Covid on Practice? Medscape survey 55% drop in revenue, 60% drop Patient Volume; 43,000 healthcare workers laid off in March 2020; 9% of practices have closed temporarily; 225% increase in remote patient engagements. https://t.co/LHeYA5pE29

Links:

Dr. John Cush @RheumNow  (  View Tweet)

Adaptive clinical trial design advocated for drug development for the coronavirus #COVID-19 https://t.co/jcEdlFQtXQ

Links:

Dr. John Cush @RheumNow  (  View Tweet)

4 patients with refractory lupus panniculitis (LEP) (mean age 15 yrs) were successfully treated with rituximab, w/ a rapid and sustained RTX response https://t.co/GxmA9w89k3

Links:

Dr. John Cush @RheumNow  (  View Tweet)

Rheums - Register for Tuesday Nite Rheumatology from Down Under - Dr. Peter Nash and Dr. Philip Robinson will discuss COVID-Rheum Registry and Rheumatology during COVID. Register here - https://t.co/PXJmUleQfw

Links:

Dr. John Cush @RheumNow  (  View Tweet)

janefingr.JPG

Systemic Sclerosis Future Therapies and Outcome Measures

Jack Cush, MD

Nagaraja, Khanna and colleagues have published an overview of current and future therapies in patients with systemic sclerosis (SSc) and have reviewed the potential outcome measures for this difficult autoimmune disorder.

Read Article
Praise and thanks should be bestowed upon our many Medical Residents working front-line on COVID-19 in the hospital. This NPR article aptly portrays their experiences and words. Bless them for smarts and dedication! https://t.co/NxBY7kAOSG

Links:

Dr. John Cush @RheumNow  (  View Tweet)

grad business career

Graduation

Jack Cush, MD

Congratulations! 

Years of training and work, all your efforts and overcoming hurdles have culminated in where you are today – on the verge of a new life, a new plan and possibly a new career.

Read Article
Free read from Schett et al on COVID and increased proinflammatory cytokines - TNF, IL-1β, IL-6, IL-8, G-CSF ^ GM-CSF; & chemokines, such as MCP1, IP10 and MIP1α, are increased with COVID-19, with higher levels in those who are critically ill. https://t.co/My9UJ0cmPn

Links:

Dr. John Cush @RheumNow  (  View Tweet)

Great shout out from @philipcrobinson on @RheumNow TUES NIGHT Rheum for my ranting Tweet which launched all the hard working people who built the @rheum_covid Alliance!!! All of the RHEUMS following me regiter your pts on the site in 5 min!! Great session @CCalabreseDO #COVID19

Leonard Calabrese @LCalabreseDO  (  View Tweet)

COVID-19 from Down Under

TNR Oz Snap

TNR - COVID-Rheumatology Registry & COVID in OZ

This week's Tuesday Nite Rheumatology features presentations and interviews with Drs. Peter Nash and Philip Robinson. Dr. Robinson presents latest data on the Rheum-Covid.org Registry, that he helped establish under the Global Rheumatology Alliance. Dr. Nash presents the impact of COVID in Australia and pragmatic COVID management.

Read Article
Thurs 8AM - start of the 2nd NIH Symposium on Autoinflammatory and immune-dysregulatory Diseases - World experts on IL-1 mediated autoinflammatory diseases, autoinflammatory Type-I interferonopathies, MAS/HLH, LIVE STREAMING AT 8AM EST https://t.co/XJ4EOIXyYm

Links:

Dr. John Cush @RheumNow  (  View Tweet)

×